Stephen J Blakemore

Title: The Innovations of Stephen J Blakemore

Introduction

Stephen J Blakemore is an accomplished inventor based in Littleton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of biomarkers related to cancer treatment. With a total of 3 patents, his work has the potential to impact therapeutic strategies significantly.

Latest Patents

Blakemore's latest patents include groundbreaking research on biomarkers of response to NAE inhibitors. These patents disclose markers whose mutational status is associated with sensitivity to treatment with NAE inhibitors. The mutational status is determined by measuring characteristics of markers associated with the marker genes. Additionally, he has developed compositions and methods to assess these markers to predict responses to NAE inhibition treatment. Another notable patent focuses on biomarkers and methods to predict responses to therapeutic agents. This patent outlines methods to identify markers for predicting treatment outcomes and provides compositions and methods to predict responses to NAE inhibition or EGFR inhibition treatment.

Career Highlights

Throughout his career, Blakemore has worked with prominent companies in the biotechnology sector, including Millennium Pharmaceuticals Limited and The General Hospital Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to innovative research.

Collaborations

Some of his notable coworkers include Bin Li and George J Mulligan. Their collaborative efforts have further advanced the research and development of therapeutic strategies in biotechnology.

Conclusion

Stephen J Blakemore's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work on biomarkers has the potential to enhance treatment strategies for patients, showcasing the importance of innovation in healthcare.